Cell Signaling Technology

Phospho-Ret (Tyr905) Antibody

#3221 · $362

100
Citing papers
15.3k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy10Cell Adhesion Molecules Research6Genomics, phytochemicals, and oxidative stress5MicroRNA in disease regulation5Adipose Tissue and Metabolism4HER2/EGFR in Cancer Research4Cancer Cells and Metastasis4Cancer Genomics and Diagnostics4

Papers citing this product

1
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
Proceedings of the National Academy of Sciences·2007·622 cit.·DOI
2
Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice
Journal of Biological Chemistry·2011·530 cit.·DOI
3
Periostin is essential for cardiac healingafter acute myocardial infarction
The Journal of Experimental Medicine·2008·460 cit.·DOI
4
Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling
Molecular Medicine·2012·443 cit.·DOI
5
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Journal of Clinical Investigation·2007·441 cit.·DOI
6
Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
The Journal of Experimental Medicine·2012·402 cit.·DOI
7
Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
Journal of Clinical Oncology·2005·364 cit.·DOI
8
Dectin-1 Stimulation by <i>Candida albicans</i> Yeast or Zymosan Triggers NFAT Activation in Macrophages and Dendritic Cells
The Journal of Immunology·2007·359 cit.·DOI
9
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
British Journal of Cancer·2008·288 cit.·DOI
10
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Journal of Clinical Investigation·2015·274 cit.·DOI
Phospho-Ret (Tyr905) Antibody — Evidence — PubIndex